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Volume 57, Number 5S Abstracts 93Sof smoking (76%). Other co-morbidities included diabetes
(47%), obesity (35%), and CAD (44%). Consistent with
previous ﬁndings, CAS was associated with higher inci-
dence of microemboli (P ¼ .0005) and with susceptibility
to memory decline (P ¼ .0085). Negative univariate asso-
ciations were found for 5-HTT (serotonin transporter)
short alleles with memory decline (P ¼ .016) and brain-
derived neurotrophic factor (BDNF) polymorphism with
incidence of microemboli (P ¼ .018). After adjusting for
ApoE risk alleles, incidence of microemboli trended with
memory decline (P ¼ .099).
Conclusions: Despite a small number of patients, our
study showed that genetic polymorphisms such as 5-HTT,
BDNF, and ApoE may provide additional insight on post-
operative changes in cognition. Further investigation of
these polymorphisms is warranted to understand and
potentially prevent cognitive deterioration following
carotid revascularization procedures.
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Objectives: The impact of degree of contralateral
stenosis on outcome after CAS and CEA remains
unknown. We aimed to identify those patients at increased
procedural risk due to contralateral stenosis or occlusion
(CO).
Methods: All patients undergoing CEA or CAS in
the Vascular Study Group of New England were identi-
ﬁed from 2003-2011. Patients were stratiﬁed by
symptom status and degree of ipsilateral stenosis. Primary
endpoint was any stroke or death (S/D) at 30 days.
Bivariate and multivariable analyses (adjusted for age,Table. Thirty-day stroke/death rate in symptomatic and asym
CS < 50% CS 50-79%
No. % No. %
ASX
Ipsi 50-80% (n ¼ 1655) 9 0.9 3 0.6
Ipsi >80% (n ¼ 4945) 18 0.7 14 0.9
SX
Ipsi 50-80% (n ¼ 1115) 10 1.4 7 2.4
Ipsi >80% (n ¼ 2195) 25 2.1 11 1.7
ASX, Asymptomatic; CO, contralateral occlusion; CS, contralateral stenosis; ISPgender and procedure) were done to assess the impact
of the degree of contralateral stenosis as assessed by
Duplex Ultrasound.
Results: 9362 CEA patients (33.4% symptomatic
[sx]) and 663 CAS patients (34.4% sx) were included.
Contralateral disease did not impact outcome in asymp-
tomatic (asx) patients with 50-80% ipsilateral stenosis.
Asx patients with ipsilateral >80% stenosis and CO had
signiﬁcantly increased S/D rate (3.4%; P < .01; OR, 5.4
[2.6-11.4]). Sx patients with >80% ipsilateral stenosis
were not impacted by contralateral stenosis, while those
with 50-80% ipsilateral stenosis and 80-99% contralateral
stenosis had the highest S/D rate (6.9%; P ¼ .05; OR,
5.1 [1.1-24.7]).
Conclusions: The impact of contralateral disease on
outcome after carotid revascularization is different for asx
vs sx patients. Regardless of procedure, CO increases the
risk for asx patients with >80% ipsilateral stenosis, while
80-99% contralateral stenosis increases the risk for sx
patients with 50-80% ipsilateral stenosis.
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Objectives: Postoperative readmission is associated
with increased morbidity and mortality. We evaluated risk
factors for readmission and postdischarge mortality
following carotid endarterectomy (CEA) in the ACS-
NSQIP.
Methods: All patients undergoing CEA without
concurrent cardiac procedure in the 2011 NSQIP were
identiﬁed. Independent predictors of 30-day readmission
and postdischarge mortality were determined using multi-
variable logistic regression.ptomatic undergoing CEA or CAS
CS 80-99% CO
P value
Total
No. % No. % No. %
0 0 1 0.9 .88 13 0.8
1 0.3 12 3.4 <.001 45 0.9
2 6.9 3 5.1 .05 22 2.0
6 3.5 2 1.7 .56 44 2.1
I, ipsilateral; SX, symptomatic.
